The CXCR3(+)CD56Bright phenotype characterizes a distinct NK cell subset with anti-fibrotic potential that shows dys-regulated activity in hepatitis C (Q34335634)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The CXCR3(+)CD56Bright phenotype characterizes a distinct NK cell subset with anti-fibrotic potential that shows dys-regulated activity in hepatitis C	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

1 August 2017

The CXCR3(+)CD56Bright phenotype characterizes a distinct NK cell subset with anti-fibrotic potential that shows dys-regulated activity in hepatitis C (English)

1 reference

Europe PubMed Central

1 August 2017

1 reference

based on heuristic

inferred from title

Benjamin Krämer

object named as

Benjamin Krämer

3

0 references

Christian Körner

object named as

Christian Körner

4

0 references

Hans Dieter Nischalke

object named as

Hans Dieter Nischalke

7

0 references

author name string

Marianne Eisenhardt

1

1 reference

Europe PubMed Central

1 August 2017

Andreas Glässner

2

1 reference

Europe PubMed Central

1 August 2017

Bernhard Sibbing

5

1 reference

Europe PubMed Central

1 August 2017

Pavlos Kokordelis

6

1 reference

Europe PubMed Central

1 August 2017

Tilman Sauerbruch

8

1 reference

Europe PubMed Central

1 August 2017

Ulrich Spengler

9

1 reference

Europe PubMed Central

1 August 2017

Jacob Nattermann

10

1 reference

Europe PubMed Central

1 August 2017

language of work or name

0 references

publication date

5 July 2012

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

7

1 reference

Europe PubMed Central

1 August 2017

7

1 reference

Europe PubMed Central

1 August 2017

e38846

1 reference

Europe PubMed Central

1 August 2017

copyright license

Creative Commons Attribution 4.0 International

5 July 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

CXCL9 and CXCL10 chemokines as predictors of liver fibrosis in a cohort of primarily African-American injection drug users with chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390318

6 July 2018

Suppression of innate immunity (natural killer cell/interferon-γ) in the advanced stages of liver fibrosis in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390318

6 July 2018

Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390318

6 July 2018

Hepatitis C virus (HCV) evades NKG2D-dependent NK cell responses through NS5A-mediated imbalance of inflammatory cytokines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390318

6 July 2018

Activation of natural killer cells inhibits liver fibrosis: a novel strategy to treat liver fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390318

6 July 2018

Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390318

6 July 2018

Innate immunity and alcoholic liver fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390318

6 July 2018

Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390318

6 July 2018

IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390318

6 July 2018

Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390318

6 July 2018

Fas ligand is responsible for CXCR3 chemokine induction in CD4+ T cell-dependent liver damage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390318

6 July 2018

Association of pretreatment serum interferon inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390318

6 July 2018

Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390318

6 July 2018

Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3390318

6 July 2018

Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038846

21 January 2018

Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038846

21 January 2018

Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038846

21 January 2018

STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038846

21 January 2018

Amelioration of hepatic fibrosis by NK cell activation.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038846

21 January 2018

Retinoic acid signaling sensitizes hepatic stellate cells to NK cell killing via upregulation of NK cell activating ligand RAE1.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038846

21 January 2018

Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038846

21 January 2018

Prospective study of natural killer cell phenotype in recurrent hepatitis C virus infection following liver transplantation.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038846

21 January 2018

Resident human hepatitis lymphocytes are phenotypically different from circulating lymphocytes

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038846

21 January 2018

Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/22792160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/22792160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing

1 reference

https://pubmed.ncbi.nlm.nih.gov/22792160

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0038846

1 reference

Europe PubMed Central

1 August 2017

2012PLoSO...738846E

0 references

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34335634&oldid=1988500220"